Home/Filings/4/0001628280-16-021749
4//SEC Filing

Bellerophon Therapeutics, Inc. 4

Accession 0001628280-16-021749

CIK 0001600132operating

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 10:57 AM ET

Size

6.8 KB

Accession

0001628280-16-021749

Insider Transaction Report

Form 4
Period: 2016-11-29
Amin Naseem
Director
Transactions
  • Purchase

    Common Stock

    2016-11-29+714,285737,650 total
  • Purchase

    Common Stock Warrants (right to buy)

    2016-11-29+714,285714,285 total
    Exercise: $0.80From: 2016-11-29Exp: 2021-11-29Common Stock (714,285 underlying)
Footnotes (1)
  • [F1]The reported securities are included within 714,285 Class A Units purchased by the reporting person for $0.70 per Class A Unit. Each Class A Unit consists of one share of common stock and one warrant to purchase one share of common stock

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001600132

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 10:57 AM ET
Size
6.8 KB